Results 81 to 90 of about 823,424 (276)
Kurarinone ameliorates EAE via the gut microbiota‐indole‐3‐acetaldehyde‐AhR axis. Kurarinone reshapes gut microbiota and increases Akkermansia muciniphila, which promotes intestinal indole‐3‐acetaldehyde production. Indole‐3‐acetaldehyde crosses the intestinal barrier, activates AhR in CD4+ T cells, upregulates SOCS1/3, inhibits JAK2 and STAT3/4 ...
Xinyan Han +11 more
wiley +1 more source
Engineered Chiral Probiotics Ameliorate MASH via Gut–Liver Axis
A chiral gold nanozyme was coated onto the gut commensal bacterium Faecalibacterium duncaniae (F. duncaniae) to create an engineered probiotic. In mouse models of MASH, this orally administered living therapeutic protected the bacterium against oxidative stress, enhanced its gut colonization, reversed steatosis, inflammation, and fibrosis, and improved
Jing Chen +12 more
wiley +1 more source
This study reveals that Bacteroides fragilis drives depression in IBS‐D patients by producing ceramide‐1‐phosphate (C1P), which inhibits hippocampal SMPD4 and disrupts myelin integrity. Translationally, dietary branched‐chain amino acid restriction or SMPD4 restoration rescues this demyelination and depressive behavior, highlighting a novel gut–brain ...
Ping Zheng +12 more
wiley +1 more source
Sesamin reshapes the diabetic gut microbiota and increases microbiota‐associated indole‐3‐carboxaldehyde availability. ICA activates intestinal AhR signaling, enhances AhR occupancy at the Gcg promoter, and promotes GLP‐1 production. GLP‐1R signaling contributes to improved glucose tolerance and early insulin responses, linking microbial metabolism to ...
Zhichao Li +13 more
wiley +1 more source
Chronic oral administration of specific probiotic strains triggers gut microbiota dysbiosis and systemic metabolic perturbations in mice. Multi‐omics profiling reveals subsequent hippocampal glial remodeling and neuroinflammation, which are linked to cognitive impairment.
Yibin Lin +15 more
wiley +1 more source
BackgroundFaecal microbiota transplantation (FMT) is recommended treatment for recurrent Clostridioides difficile infection and is studied as a potential modifier of other gastrointestinal and systemic disorders. Autologous FMT limits the potential risks
Måns Stefansson +7 more
doaj +1 more source
Faecal microbiota transplantation for Clostridium difficile infection
To review the current clinical literature regarding the use of fecal microbiota transplantation (FMT) for severe and recurrent Clostridium difficile disease (CDAD).Clostridium difficile (C. difficile) is a gram positive, spore forming bacteria, and an important nosocomial pathogen causing healthcare associated diarrhoea in hospitalized patients in ...
M, Dodin, D E, Katz
openaire +2 more sources
Chlorinated paraffins (CPs) disrupt mitochondrial redox homeostasis, causing oxidative stress and gut‐liver axis dysfunction that ultimately drives lipid metabolic disorders. Inspired by natural Mn‐SOD, we developed oxygen‐bridged MIL‐100(Mn) nanozymes with enhanced SOD/CAT‐like cascade activity. Oral administration restored CP‐induced lipid metabolism
Qi Zhang +12 more
wiley +1 more source
Colonic in situ microbiota differ markedly from fecal microbiota in children with autism spectrum disorder and show stronger links with clinical severity. Washed microbiota transplantation remodels this intestinal microbial compartment toward donor‐like profiles, while models combining colonic microbiota and clinical features improve prediction of ...
Hong‐Qian Liu +10 more
wiley +1 more source
AN OVERVIEW OF FAECAL MICROBIOTA TRANSPLANTATION
Faecal Microbiota Transplant (FMT) is a medical intervention in which stool from a healthy person is transplanted into another individual’s large intestine. This method is meant to help restore the normal microbiota of the recipient’s gut, including cases with dysbiosis due to recurrent Clostridium difficile infection and other gastrointestinal ...
SOLOMON MATTHIAS GAMDE +4 more
openaire +1 more source

